[DOI] [PMC free article] [PubMed] [Google Scholar] 76.Ward P.S., Patel J., Wise D.R., Abdel-Wahab O., Bennett B.D., Coller H.A., Cross J.R., Fantin V.R., Hedvat C.V., Perl A.E., et al
Recently, the Sawyer group has shown that it is possible to use structural and modeling data to chemically design and guide modifications of the enzalutamide structure to restore antagonism in the presence of the F876L mutation 176
Additionally, the identification of susceptible populations and critical exposure windows requires more sophisticated biomarker approaches and personalized risk assessment tools
Potential side effects can include bruising at the cannula site, a temporary drop in blood pressure (particularly with rapid magnesium delivery), nausea, or lightheadedness
Twickler MT, Cramer MJ, Koppeschaar HP: Unraveling Reavens syndrome X: serum insulin-like growth factor-I and cardiovascular disease
Key Features: Copper-binding peptide promoting cellular regeneration and repair
